BRPI0921148A2 - composto, método para tratar uma infecção bacteriana, e, uso de um composto. - Google Patents

composto, método para tratar uma infecção bacteriana, e, uso de um composto.

Info

Publication number
BRPI0921148A2
BRPI0921148A2 BRPI0921148A BRPI0921148A BRPI0921148A2 BR PI0921148 A2 BRPI0921148 A2 BR PI0921148A2 BR PI0921148 A BRPI0921148 A BR PI0921148A BR PI0921148 A BRPI0921148 A BR PI0921148A BR PI0921148 A2 BRPI0921148 A2 BR PI0921148A2
Authority
BR
Brazil
Prior art keywords
compound
treating
bacterial infection
bacterial
infection
Prior art date
Application number
BRPI0921148A
Other languages
English (en)
Inventor
Bolin Geng
Folkert Reck
Mark Cronin
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of BRPI0921148A2 publication Critical patent/BRPI0921148A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5383—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
BRPI0921148A 2008-11-14 2009-11-13 composto, método para tratar uma infecção bacteriana, e, uso de um composto. BRPI0921148A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US11470608P 2008-11-14 2008-11-14
US16384809P 2009-03-26 2009-03-26
PCT/GB2009/051532 WO2010055348A1 (en) 2008-11-14 2009-11-13 [4- (1-amino-ethyl) -cyclohexyl] -methyl-amines as antibacterials

Publications (1)

Publication Number Publication Date
BRPI0921148A2 true BRPI0921148A2 (pt) 2016-02-23

Family

ID=41463108

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0921148A BRPI0921148A2 (pt) 2008-11-14 2009-11-13 composto, método para tratar uma infecção bacteriana, e, uso de um composto.

Country Status (20)

Country Link
US (1) US20110288084A1 (pt)
EP (1) EP2370444A1 (pt)
JP (1) JP2012508789A (pt)
KR (1) KR20110093797A (pt)
CN (1) CN102216308A (pt)
AR (1) AR074340A1 (pt)
AU (1) AU2009315425A1 (pt)
BR (1) BRPI0921148A2 (pt)
CA (1) CA2742520A1 (pt)
CO (1) CO6382113A2 (pt)
CR (1) CR20110256A (pt)
CU (1) CU20110108A7 (pt)
EA (1) EA201100754A1 (pt)
EC (1) ECSP11011053A (pt)
IL (1) IL211941A0 (pt)
MX (1) MX2011005106A (pt)
TW (1) TW201022279A (pt)
UY (1) UY32247A (pt)
WO (1) WO2010055348A1 (pt)
ZA (1) ZA201104395B (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2723737A1 (en) * 2011-06-27 2014-04-30 Kyorin Pharmaceutical Co., Ltd. Bridged bicyclic compounds for the treatment of bacterial infections
AR096135A1 (es) * 2013-05-02 2015-12-09 Actelion Pharmaceuticals Ltd Derivados de la quinolona
UY36851A (es) * 2015-08-16 2017-03-31 Glaxosmithkline Ip Dev Ltd Compuestos para uso en aplicaciones antibacterianas
US10029995B2 (en) 2015-09-03 2018-07-24 Forma Therapeutics, Inc. [6,6] fused bicyclic HDAC8 inhibitors
JP2019517546A (ja) * 2016-06-08 2019-06-24 アジェンデ・キミケ・リウニテ・アンジェリニ・フランチェスコ・ア・チ・エレ・ア・エフェ・ソシエタ・ペル・アチオニＡｚｉｅｎｄｅ Ｃｈｉｍｉｃｈｅ Ｒｉｕｎｉｔｅ Ａｎｇｅｌｉｎｉ Ｆｒａｎｃｅｓｃｏ Ａ．Ｃ．Ｒ．Ａ．Ｆ．Ｓｏｃｉｅｔａ Ｐｅｒ Ａｚｉｏｎｉ 新しい抗菌性化合物
WO2018225097A1 (en) * 2017-06-08 2018-12-13 Bugworks Research India Pvt Ltd Heterocyclic compounds useful as anti-bacterial agents and method for production thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY150958A (en) * 2005-06-16 2014-03-31 Astrazeneca Ab Compounds for the treatment of multi-drug resistant bacterial infections
SG164384A1 (en) * 2006-05-26 2010-09-29 Toyama Chemical Co Ltd Novel heterocyclic compound or salt thereof and intermediate thereof
CL2007003693A1 (es) * 2006-12-22 2008-06-27 Actelion Pharmaceuticals Ltd Compuestos derivados de pirido [3,2-b] [1,4] tiazina; composicion farmaceutica que contiene dichos compuestos; y su uso en el tratamiento de infecciones bacterianas.

Also Published As

Publication number Publication date
CR20110256A (es) 2011-07-04
ECSP11011053A (es) 2011-06-30
JP2012508789A (ja) 2012-04-12
ZA201104395B (en) 2012-03-28
AR074340A1 (es) 2011-01-12
KR20110093797A (ko) 2011-08-18
CU20110108A7 (es) 2012-01-31
IL211941A0 (en) 2011-06-30
WO2010055348A1 (en) 2010-05-20
UY32247A (es) 2010-06-30
CA2742520A1 (en) 2010-05-20
AU2009315425A1 (en) 2010-05-20
TW201022279A (en) 2010-06-16
CN102216308A (zh) 2011-10-12
US20110288084A1 (en) 2011-11-24
EP2370444A1 (en) 2011-10-05
CO6382113A2 (es) 2012-02-15
EA201100754A1 (ru) 2012-01-30
MX2011005106A (es) 2011-05-30

Similar Documents

Publication Publication Date Title
BRPI0815057A2 (pt) Composto, composição farmacêutica, e, método para tratar infecção.
BRPI0922475A2 (pt) composto, composição farmacêutica , método para tratar câncer, e, uso de um composto.
BRPI0820474A2 (pt) método de tratamento de uma doença, uso de composto, e, composto
BRPI1013984A2 (pt) composto , composição farmacêutica, método para tratamento ou profilaxia de uma doença ou condição, e, uso de um composto.
BRPI0815409A2 (pt) Cepa bacteriana, processos para a produção fermentativa de um composto, e para a produção de um composto, e, uso de uma cepa bacteriana.
BRPI1010775A2 (pt) composição, método para preparar uma composição, e, uso de uma composição.
BRPI1008383A2 (pt) composto, composição farmacêutica, método para prevenir, inibir ou tratar uma condição, e, uso de um composto
BRPI0917458A2 (pt) composto, método de tratamento de doenças e condições, composição farmacêutica, método para tratar ou prevenir doença, e, uso de um composto
BRPI0920263A2 (pt) composto, uso do composto, composição, e, método
BRPI0908100A2 (pt) produto combinação, uso de um composto, e, método de tratar câncer
BRPI0813237A2 (pt) Composto, método para preparar o composto, composição, medicamento, e, uso do composto.
BR112012022879A2 (pt) composto, composição farmacêutica, uso do composto e método de tratamento
BRPI0814941A2 (pt) Composição de tratamentode semente, e, método de tratamento de semente.
BRPI0919937A2 (pt) composto, e, método para melhorar a atividade de adjuvante de uma imidazoquinolina
BRPI0907976A2 (pt) Composto, composição farmacêutica, uso de um composto, e, método para tratar ou prevenir doenças
BRPI0912539A2 (pt) composto, composição farmacêutica , método para tratar uma doença, e, uso do composto.
BRPI0908635A2 (pt) composto, composição farmacêutica e método de tratamento de câncer
BRPI0907974A2 (pt) Composto, composição farmacêutica, uso de um composto, e, método para tratar ou prevenir doenças
BRPI0814300A2 (pt) Composto, composição farmacêutica, e, método para tratar uma infecção viral
BRPI0815591A2 (pt) Composto, composição farmacêutica, uso de um composto, e, método para tratar uma doença, condição ou distúrbio.
BRPI0916649A2 (pt) Composto, composição, uso de um composto, e, método para exterminar ou inibir o crescimento de uma espécie de plasmodium.
BRPI0908883A2 (pt) composto, composição farmacêutica, uso de um composto, e, método para tratar ou prevenir doenças
BRPI0818323A2 (pt) composição farmacêutica, uso de uma composição farmacêutica, e, método para tratar câncer.
BRPI0923856A2 (pt) composto, composição farmacêutica, uso de um composto, e método para tratar uma doença ou distúrbio.
BRPI0916885A2 (pt) composição farmacêutica, e, método para tratar uma infecção bacteriana

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]